Poster Information 

 

PRESENT A POSTER AND SAVE $50! 

 

Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by March 20, 2015. 

Register online, or by phone, fax or mail.  Please indicate that you would like to present a poster.  Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool.  Please see below for more information. 

Reasons you should present your research poster at this conference: 

  • Your poster will be exposed to our international delegation 
  • Receive $50 off your registration 
  • Your poster abstract will be published in our conference materials 
  • Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes 


Note: Posters should be portrait orientation, with maximum dimensions of
36 inches wide (3 feet) x 48 inches high (4 feet).
 


Click here for poster instructions 
 

Poster inquiries: jring@healthtech.com

 

 

Partial List of 2014 Poster Titles:

  • Albert-Ludwigs-Universität - Discovery of XD14, a Potent BET Bromodomain Inhibitor
  • Arizona State University - In situ measurement on drug-receptor binding kinetics in single cells: A surface plasmon resonance imaging study on anti-tumor drug resistance
  • Arizona State University - Intracellular Dynamics Imaging: Using Surface Plasmon Resonance Microscopy
  • Arizona State University - Ribosome Mediated Incorporation of β-Amino Acids into Protein
  • AstraZeneca Pharmaceuticals - Discovery and Optimization of 1-methyl-1H-imidazole Derivatives as Potent Jak2 Inhibitors
  • Atlantic Cancer Research Institute - Macrocyclic Head-to-Tail Alpha-Peptoids: A Gateway to Therapeutics
  • Bio-Rad Laboratories, Inc. - Novel Liposome-Capture Surface Chemistries to Analyze Drug-Lipid Interaction Using the ProteOn XPR36 System
  • Chemical Computing Group, Inc. - A Computational Approach for Performing Medicinal Chemistry Transformations Within a 3D Active Site
  • Chemical Computing Group, Inc. - Application of Extended Hückel Theory to Pharmacophore Discovery
  • China Medical University - Immunosuppressive Effect of Methanolic Extract and Eugenol of Caryophyllata Flos on Dendritic Cell Activation and Function
  • Cisbio Bioassays - EPIgeneous Methyltransferase Assay: A New HTRF Universal SAH Detection Assay to Assess Methyltransferase Activity
  • Collaborative Drug Discovery, Inc. - Leveraging CDD Vault™'s Kinome Data to Build Predictive Models of Kinase Activity
  • DiscoveRx Corporation - Rational Design of Dual Kinase-Bromodomain Inhibitors for Therapeutic Polypharmacology
  • Dotmatics, Inc. - Automated Mass Spectrometry Data Analysis for Antibody Drug Conjugates
  • Dotmatics, Inc. - Keeping the Thrill Alive: Data on Demand
  • Dotmatics, Inc. - How to Choose the Right Electronic Lab Notebook
  • EMD Serono Research and Development Institute, Inc. - Discovery of Substituted Benzamides as Follicle Stimulating Hormone Receptor Allosteric Modulators
  • ETH Zurich - DNA-Encoded Self-Assembling Chemical (ESAC) Library Technology: A Promising Tool for Lead Expansion of Small Organic Ligands Used in Tumor Targeting
  • Ewha Womans University - Identification of Allosteric Hot Spots and Multiple Signaling Pathways of A2A Adenosine Receptor Using Network Analysis
  • GE Healthcare - “The Whole Is Greater Than the Sum of Its Parts” - Hit Selection and the Power of Orthogonality
  • GlaxoSmithKline - Peptide Therapeutics for Intracellular PPIs: A Stapled Peptide Approach
  • Glenmark Pharmaceuticals Ltd. - Novel, Orally Available, Potent and Selective Retinoid Related Orphan Receptor-c (RORc) Inhibitors for Potential Treatment of Autoimmune Diseases
  • H. Lundbeck A/S - The Discovery of Novel Selective Phosphodiesterase 10A (PDE10A) Inhibitors from a Low Molecular Weight Hit with an Unexpected Binding Mode
  • Hunter College - Design and Synthesis of Water Soluble Chlorin with Active Linker for Biological Targets
  • Imperial College London - Development of a Highly Potent and Selective CDK7 Inhibitor
  • Institute of Cancer Research - Synthesis and Kinome Selectivity Patterns of Imidazo[4,5-b]pyridine-Derived Fragment Libraries
  • Institute of Chemical and Engineering Sciences, A*STAR - Bicyclo[1.1.1]pentane Derivatives for Fragment-Based Drug Discovery
  • IntelliSynRD - Development of Highly Potent, Selective BET Bromodomain Inhibitors That Are CNS Penetrant and Effective in Rodent Models of Brain Cancer
  • International Islamic University Malaysia - Design of Phosphoinositide-3-Kinase B (PI3Kβ) Isoform Inhibitors Through Group-Based Quantitative Structure Activity Relationship (GQSAR) and Molecular Docking
  • King Saud University - Synthesis, Single-Crystal, In Vitro Antitumor Evaluation and Molecular Docking of 3-Substituted 5,5-Diphenylimidazolidine-2,4-Dione Derivatives
  • King Saud University - Synthesis and Anticancer Activity of Some Novel Trifluoromethylquinolines Carrying a Biologically Active Benzenesulfonamide Moiety
  • King Saud University - Evaluation of Some Biological Activities of Albizia lebbeck Flowers
  • Kyung Hee University - Regulation of Syndecan-1 Mediated Signaling by Insulin in UMR-106 Cells
  • Leidos Biomedical Research, Inc. - Biochemical Characterization and Computational Analysis of Phenylglycine Inhibitors of Mutant IDH1
  • Life Chemicals, Inc. - Screening Compound Libraries for HTS and Lead Discovery Projects
  • Life Chemicals, Inc. - Fragment and Other Compound Libraries from Life Chemicals
  • MBL International Corporation - A Novel Technology to Visualize Protein-Protein Interactions in Living Cells
  • Merck & Co., Inc. - Efficient Biochemical Validation of Fragment Screening Hits
  • Merck & Co., Inc. - Design and Development of (Benz)Imidazole Pyridones as JAK1-Selective Kinase Inhibitors
  • Moscow Institute of Physics and Technology - Design and Synthesis of “Recognition Element” Mimetics Targeting PPI
  • Moscow Institute of Physics and Technology - New Strategy of Drug-Like Macrocyclic Scaffolds and Libraries Design
  • National Institute of Chemistry, Slovenia - Structure-Based Discovery of Novel Low Molecular Weight DNA Gyrase B Inhibitors
  • National Taiwan University - Novel Benzoyluriedoindolin-2-One Dervatives as Potent Aurora B Inhibitors
  • National Taiwan University - Selective Histone Deacetylase-6 Inhibitors as Neurite Outgrowth Modulators
  • Netherlands Translational Research Center - Drug Sensitivity Markers for Approved Kinase Inhibitor Drugs from Cell Panel Profiling
  • Netherlands Translational Research Center - Next Generation Kinase Panel Screening Measuring Target Residence Time and Kinetic Selectivity
  • North Carolina State University - In Silico Drug Discovery Using QM/MM and AI Search
  • Philipps-University Marburg - Frag2Xtal: Computer-Assisted Direct Crystallographic Fragment Screening
  • Philipps-University Marburg - Structure-Based Identification of Inhibitors of NHR2 Tetramerization
  • Promega Corporation - Monitoring Interaction on Chromatin in Living Cells Using BRET Technology
  • Purdue University - Using Peptide-Based Biosensors to Detect Anaplastic Lymphoma Kinase Activity by Sensitization of Terbium Luminescence
  • Purdue University - High-Throughput Optimization of a Cell-Based Kinase Assay for Bcr-Abl Inhibition
  • QuantumBio, Inc. - Quantum Mechanics-Based Macromolecular X-Ray Refinement: The Impact of Advanced Refinement Methods on Our Understanding of Protein:Ligand Structure and Function
  • Salman bin Abdulaziz University - Inhibition of Human Carbonic Anhydrase Isozymes I, II, IX and XII with a New Series of Sulfonamides Incorporating Aroylhydrazone-,[1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl Moieties
  • Scripps Research Institute - Development of Rigid Peptidomimetic Libraries for Drugging Mutant p53
  • St. Jude Children's Research Hospital - Exploiting the Glutamine Residue in the ZA Channel to Improve the Selectivity of Bromodomain Inhibitors
  • Takeda Pharmaceutical Company - Identification and Characterization of a Novel Dual Mcl-1/Bcl-xL Inhibitor by a Simple and Widely Applicable Validation Method Based on a Quantitative Biochemical Binding Assay
  • Thapar University Patiala - Synthesis, Antitumor Activity, DNA Intercalation of Naphthalimide and Pyridine Based Derivatives
  • Thermo Fisher Scientific - Quantitative Immunoprecipitation (qIP) Assay: A Novel High-Throughput-Compatible Approach to Protein-Protein Interaction Assay
  • Tufts University - Cyclic Peptide Inhibitors of EHD1
  • Tufts University - Comprehensive Analysis of Hot Loops at Protein-Protein Interfaces as Targets for Macrocyclic Inhibitors
  • University of Copenhagen - Targeting PSD-95, a PDZ Domain Protein-Protein Interaction Target in the Brain
  • University of Malaya - Carbon-Carbon Double Bonds Reduction of Chalcone Using Phenylsulfonyl Hydrazide
  • University of Malaya - A New Indole-Based Pt(II) Complex as a Cancer-Selective Cytotoxic Agent
  • University of Malaya - Peptide-Binding to Dengue Virus Envelope Protein: Docking and MD Simulations Studies
  • University of Minnesota - Aromatic Amino Acids Have Privileged Side-Chains for Protein-Protein Interaction Inhibitor Discovery
  • University of North Carolina at Chapel Hill - Peptides Derived from PLC-Beta-3 Inhibit G-Alpha-q Signaling
  • University of Strathclyde - Understanding the Rhythm of Pulmonary Inflammation
  • University of the Pacific - Design and Optimization of Mutant Selective Platelet Derived Growth Factor Receptor (PDGFR) Family Kinase Inhibitors
  • University of the Philippines - Structure-Based Pharmacophore Screening, Molecular Docking, and In Silico Toxicity Evaluation of Compounds Againast Mycobacterium Tuberculosis L,D - transpeptidase 2 (LdtMt2)
  • University of Torino - Toward a Bioisosteric Alkaest – Application to the Bioisosteric Modulation of IMD-0354
  • X-Chem, Inc. - DNA-Encoded Chemistry: A New Approach to PPI and Other Difficult Targets